IABP: Inflated Hopes or Deflated Use? SCAI Staging and Cardiogenic Shock Controversies in Clinical Trials
Presenter
Shashank S Sinha, MD, MSc, Inova Health System, Falls Church, VA
Shashank S Sinha, MD, MSc, Inova Health System, Falls Church, VA
Learning Objectives:
- Briefly Review SCAI Staging
- Discuss differences between stages of CS in ACC Consensus Guidance Document & ACS Guidelines
- Discuss ECLS Shock, DanGer Shock, Alt Shock 2 Trial – How has CS Staging & Phenotypes impacted the understanding of CS.